Reproductive and Physical Health

Health of Women with Intellectual Disabilities

Volumn , Issue , 2008, Pages 22-40

  van Schrojenstein Lantman de Valk, Henny M J ^a   Schupf, Nicole ^b,c   Patja, Kristiina ^d  

^a Department of General Practice ^*  (Netherlands)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c Vagelos College of Physicians and Surgeons   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Age related health problems; Contraceptives; Intellectual disabilities; Physical health; Reproductive health

Indexed keywords

EID: 84957608914     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470776162.ch2     Document Type: Chapter

References (76)

1. Achterberg J., Collerrain I.&Craig P. (1978)Apossible relationship between cancer, mental retardation and mental disorders. Social Science & Medicine, 12 (3), 135.
2. Aman, M.G. (1990) Considerations in the use of psychotropic drugs in elderly mentally retarded persons. Journal of Mental Deficiency Research, 34, 1-10.
3. Aman, M.G. & Singh, N.N. (1988) Patterns of drug use, methodological considerations, measurement techniques, and future trends. In: Psychopharmacology of the Developmental Disabilities (eds M.G. Aman & N.N. Singh), pp. 1-28. Springer-Verlag, Berlin.
4. Aman, M.G., Field, C.J. & Bridgeman, G.D. (1985) Citywide survey of drug patterns among non-institutionalized retarded persons. Applied Research in Mental Retardation, 5, 159-171.
5. Anderson, D.J., Lakin, K.C., Bruiniks, R.H. & Hill, B.K. (1987) A National Study of Residential and Support Services for Elderly Persons with Mental Retardation. Report # 22. Department of Educational Psychology, University of Minnesota, Minneapolis, Minn.
6. Bachman, D.L., Wolf, P.A., Linn, R.T., Knoefel, J.E., Conn, J.L., Belanger, A.J., White, L.R. & D'Agostino, R.B. (1993) Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology, 43, 515-519.
7. Baldessarini, R.J., Coyne, B.M. & Teicher, M.H. (1988) Significance of neuroleptic dose and plasma levels in the pharmacological treatment of psychosis. Archives of General Psychiatry, 45, 79-91.
8. Barrett-Conner, E. & Kritz-Silverstein, D. (1993) Estrogen replacement therapy and cognitive function in older women. JAMA, 269, 2637-2641.
9. Baumeister, A.A., Todd, M.E. & Selvin, J.A. (1993) Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation. Clinical Neuropharmacology, 16, 271-294.
10. Brandt, B.R. & Rosen, I. (1998) Impaired peripheral somatosensory function in children with Prader-Willi syndrome. Neuropediatrics, 29 (3), 124.
11. Burger, P.C. & Vogel, F. (1973) The development of pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. American Journal of Pathology, 73, 457-468.
12. Cambridge, P. & Brown, H. (eds) (1997) HIV and Learning Disability. BILD, Kidderminster.
13. Campbell, W.A., Lowther, J., McKenzie, I. & Price, W.H. (1982) Serum gonadotrophins in Down's syndrome. Journal of Medical Genetics, 19, 98-99.
14. Carlson, G. & Wilson, J. (1996) Menstrual management and women who have intellectual disabilities: service providers and decision-making. Journal of Intellectual and Developmental Disability, 21, 39-57.
15. Carr, J. & Hollins, S. (1995) Menopause in women with learning disabilities. Journal of Intellectual Disability Research, 39, 137-139.
16. Carter, G. & Jancar, J. (1983) Mortality in the mentally handicapped: a 50 year survey at the Stoke Park group of hospitals (1930-1980). Journal of Mental Deficiency Research, 27 (2), 143.
17. Center, J.R., McElduff, A. & Beange, H. (1994) Osteoporosis in groups with intellectual disability. Australian and New Zealand Journal of Developmental Disability, 19, 251-258.
18. Center, J., Beange, H. & McElduff, A. (1998) People with mental retardation have an increased prevalence of osteoporosis: a population study. American Journal on Mental Retardation, 103, 19-28.
19. Conway, G.S., Hettiarachchi, S., Murray, A. & Jacobs, P.A. (1995) FrX pre-mutations in familial premature ovarian failure. Lancet, 346, 309-310.
20. Cooke, L.B. (1997) Cancer and learning disability. Journal of Intellectual Disability Research, 41 (4), 312-316.
21. Cooper, D.A., Eldridge, A.L. & Peters, J.C. (1999) Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research. Nutrition Reviews, 57 (7), 201.
22. Cosgrave, M.P., Tyrrell, J., McCarron, M., Gill, M. & Lawlor, B.A. (1999) Age at onset of dementia and age of menopause in women with Down's syndrome. Journal of Intellectual Disability Research, 43, 461-465.
23. Cowie, M. & Fletcher, J. (1998) Breast awareness project for women with a learning disability. British Journal of Nursing, 7, 774.
24. Ellis, W.G., McCulloch, J.R. & Corley, C.L. (1974) Pre-senile dementia in Down's syndrome. Neurology, 24, 101-106.
25. Farrer, M.J., Crayton, L., Davies, G.E., Oliver, C., Powell J., Holland, A.J.&Kessing, A.M. (1997) Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down's syndrome. Neuroreport, 8, 1645-1649.
26. Goldstein, H. (1988) Menarche, menstruation, sexual relations and contraception of adolescent females with Down's syndrome. European Journal of Obstetric Gynecology and Reproductive Biology, 27, 343-349.
27. Grech, V. & Gatt, M. (1999) Syndromes and malformations associated with congenital heart disease in a population-based study. International Journal of Cardiology, 68, 151-56.
28. Hand, J.E. (1994) Report of a national survey of older people with lifelong intellectual handicap in New Zealand. Journal of Intellectual Disability Research, 34, 275-287.
29. Hasen, J., Boyar, R.M. & Shapiro, L.R. (1980) Gonadal function in trisomy 21. Hormone Research, 12, 345-350.
30. Henderson, V.W., Paganini-Hill, A., Miller, B.K., Eible, R.J., Reyes, P.F., Shoupe, D., McCleary, C.A., Klein, R.A., Hake, A.M. & Farlow M.R. (2000) Estrogen for Alzheimer's disease in women: randomized, double-blind placebo-controlled trial. Neurology, 54, 295-301.
31. Hestnes, A., Stovener, L.J., Husoy, O., Folling, A., Fougner, K.J. & Sjaastad, O. (1991) Hormonal and biochemical disturbances in Down's syndrome. Journal of Mental Deficiency Research, 35, 179-193.
32. Hsiang, Y-H.H., Berkovitz, G.D., Bland, G.L., Migeon, C.J. & Warren, A.C. (1987) Gonadal function in patients with Down's syndrome. American Journal of Medical Genetics, 27, 449-458.
33. Huovinen, K.J.L. (1993) Gynecological problems of mentally retarded women. Acta Obstetrica Gynecologica Scandinavia, 72, 475-480.
34. Intagliata, J. & Rinck, C. (1985) Psychoactive drug use in public and community residential facilities for mentally retarded persons. Psychopharmacological Bulletin, 21, 268-278.
35. Jancar, J. (1990) Cancer and mental handicap: a further study (1976-85). British Journal of Psychiatry, 156, 531.
36. Jancar, M.P. & Jancar, J. (1977) Cancer and mental retardation. Bristol MedicoChirurgical Journal, 92, 341-342.
37. Jancar, J., Eastham, R.D. & Carter, G. (1984) Hypocholesterolaemia in cancer and other causes of death in the mentally handicapped. British Journal of Psychiatry, 145, 59.
38. Janicki, M.P. & Jacobson, J.W. (1986) Generational trends in sensory, physical, and behavioral abilities among older mentally retarded persons. American Journal of Mental Deficiency, 90, 490-500.
39. Jones, R.G. & Kerr, M.P. (1997) A randomized control trial of an opportunistic health screening tool in primary care for people with intellectual disability. Journal of Intellectual Disability Research, 41, 409-415.
40. Kapell, D., Nightingale, B., Rodriguez, A., Lee, J.H., Zigman, W.B. & Schupf, N. (1998) Prevalence of chronic medical conditions in adults with mental retardation: comparison with the general population. Mental Retardation, 36, 269-279.
41. Lai, F. & Williams, R.S. (1989) A prospective study of Alzheimer disease in Down's syndrome. Archives of Neurology, 46, 849-853.
42. Lai, F., Kammann, E., Rebeck, G.W., Anderson, A., Chen, Y. & Nixon, R.A. (1999) APOE genotype and gender effects on Alzheimer disease in 100 adults with Down's syndrome. Neurology, 53, 331-336.
43. Lindgren, G.E. & Katoda H. (1993) Maturational rate of Tokyo children with and without mental retardation. American Journal on Mental Retardation, 98, 1228-1234.
44. Malamud, N. (1972) Neuropathology of organic brain syndromes associated with aging. In: Aging and the Brain (ed. C.M. Gaitz) pp. 63-77. Plenum, New York.
45. Marozzi, A., Vegetti, W., Manfredinji, E., Tibiletti, M.G., Testa, G., Crosignani, P.G., Gineeli, E., Meneveri, R. & Dalpra, L. (2000) Association between idiopathic premature ovarian failure and fragile X pre-mutation. Human Reproduction, 15, 197-202.
46. Martinez-Cue, C., Baamonde, C., Lumbreras, M.A., Vallina, I.F., Dierssen, M. & Florez, J. (1999) A murine model for Down's syndrome shows reduced responsiveness to pain. Neuroreport, 10 (5), 1119.
47. McCarthy, M. (1999) Sexuality and Women with Learning Disabilities. Jessica Kingsley, London.
48. McGrath, P.J., Rosmus, C., Canfield, C., Campbell, M.A. & Hennigar, A. (1998) Behaviors caregivers use to determine pain in non-verbal, cognitively impaired individuals. Developmental Medicine & Child Neurology, 40 (5), 340.
49. McLachlan, R. & Peppin, P. (1986) Sexuality and Contraception for Developmentally Handicapped Persons. Canadian Family Physician, 32, 1631-7.
50. Mortel, K.F. & Meyer, J.S. (1995) Lack of postmenopausal estrogen therapy and risk of dementia. Journal of Neuropsychiatry and Clinical Neuroscience, 14, 332-337.
51. Mulnard, R.A., Cotman, C.W. & Kawas, C.W. (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Journal of the American Medical Association, 283, 1007-1015.
52. Murray A., Webb, J., MacSwiney, F., Shipley, E., Morton, N.E. & Conway, G.S. (1999) Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA pre-mutation women. Human Reproduction, 14, 1217-1218.
53. Murray, A., Enis, S., MacSwiney, F., Webb, J. & Morton, N.E. (2000) Reproductive and menstrual history of females with fragile X expansions. European Journal of Human Genetics, 8, 247-252.
54. Oster, J. (1953) Mongolism. Danish Science Press Ltd, Copenhagen.
55. Paganini-Hill, A. & Henderson, V.W. (1994) Estrogen deficiency and risk of Alzheimer's disease in women. American Journal of Epidemiology, 140, 256-261.
56. Pary, R. (1993) Psychoactive drugs used with adults and elderly adults who have mental retardation. American Journal on Mental Retardation, 98, 121-127.
57. Patja, K., Molsa, P., Iivanainen, M. & Vesala, H. (2001) Cause-specific mortality of people with intellectual disability in a population-based, 35-year follow-up study. Journal of Intellectual Disability Research, 45, 30-40.
58. Raghavan, R., Khin-Nu, C., Brown, A.G., Day, K.A., Tyrer, S.P., Ince, P.G., Perry, E.K. & Perry, R.H. (1994) Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21). Neuroreport, 5, 1393-1396.
59. Rimmer, J.H., Braddock, D. & Fujiura, G. (1994) Cardiovascular risk factor levels in adults with mental retardation. American Journal on Mental Retardation, 98, 510-518.
60. Ropper, A.H. & Williams, R.S. (1980) Relationship between plaques, tangles, and dementia in Down's syndrome. Neurology, 30, 639-644.
61. van Schrojenstein Lantman-de Valk, H.M.J., Metsemakers, J.F.M., Haveman, M.J. & Crebolder, H.F.J.M. (2000) Health problems in people with intellectual disability in general practice: a comparative study. Family Practice, 17, 405-407.
62. Schupf, N., Zigman, W., Kapell, D., Lee, J.H., Kline, J. & Levin, B. (1997) Early menopause in women with Down's syndrome. Journal of Intellectual Disability Research, 41, 264-7.
63. Schupf, N., Kapell, D., Nightingale, B., Rodrigyez, A., Tycko, B. & Mayeux, R. (1998) Earlier onset of Alzheimer's disease in men with Down's syndrome. Neurology, 50, 991-995.
64. Schwartz, C.E., Dean, J., Howard-Peebles, P.N., Bugge, M., Mikkelsen, M., Tommerup, N., Hull, C., Hagerman, R., Holden, J.J.A. & Stevenson, R.E. (1994) Obstetrical and gynecological complications in Fragile X carriers: a multi-center study. American Journal of Medical Genetics, 51, 400-402.
65. Scola, P.S. & Pueschel, S.M. (1992) Menstrual cycles and basal body temperature curves in women with Down's syndrome. Obstetrics and Gynecology, 79, 91-94.
66. Scott, J.C. & Hochberg, M.C. (1993) Arthritis and other musculoskeletal diseases. In: Chronic Disease Epidemiology and Control (eds R.C. Brownson, P.L. Remington, & J.R. Davis). pp. 285-305. American Public Health Association, Washington DC.
67. Servais, L., Hoyois, P. & Rousseaux, J.P. (1999) Sterilizing People with Learning Disabilities: a problem belonging to the past? European Journal of Mental Disability, 6, 4-14.
68. Simpkins, J., Meharvan, S. & Bishop, J. (1994) The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiology of Aging, 15, Supplement 2, 5195-5197.
69. Stampfer, M.J., Colditz, G.A., Willet, M.C., Manson, J.E., Rosner, B., Speizer, F.E. & Hennekens, C.H. (1991) Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the Nurses Health Study. New England Journal of Medicine, 325, 756-762.
70. Tang, M.X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, K.B., Andrews, H. & Mayeux, R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429-432.
71. Tyler, C.V., Synder, C.W. & Zyzanski, S. (2000) Screening for osteoporosis in community-dwelling adults with mental retardation. Mental Retardation, 38, 316-321.
72. Uno, Y. (1996) Mental retardation and colorectal disease: colonoscopic mass screening to determine whether the risk of adenomatous polyposis syndrome is increased in the mentally retarded. Journal of Gastroenterology & Hepatology, 11 (3), 275.
73. Visser, F.E., Aldenkamp, A.P., van Huffelen, A.C., Kuilman, M., Overweg, J. & van Wijk, J. (1997) Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down's syndrome. American Journal on Mental Retardation, 101, 400-412.
74. Walsh, P.N., Heller, T., Schupf, N. & van Schrojenstein Lantman-de Valk, H.M.J. (2000) Healthy Aging Adults with Intellectual Disabilities: Women's Health Issues. World Health Organization, Geneva.
75. Wingfield, M., Healy, D.L. & Nicholson, A. (1994) Gynecological care for women with intellectual disability. The Medical Journal of Australia, 160, 536-538.
76. Zigman, W., Silverman, W. & Wisniewski, H.M. (1996) Aging and Alzheimer disease in Down's syndrome: Clinical and pathological changes. Mental Retardation and Developmental Disabilities Research Reviews, 2, 73-79.